- Home
- PRPO vs ONFO Comparison
PRPO vs ONFO Comparison
Compare PRPO & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- ONFO
- Stock Information
- Founded
- PRPO N/A
- ONFO 2018
- Country
- PRPO United States
- ONFO United States
- Employees
- PRPO N/A
- ONFO N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- ONFO Computer Software: Programming Data Processing
- Sector
- PRPO Industrials
- ONFO Technology
- Exchange
- PRPO Nasdaq
- ONFO Nasdaq
- Market Cap
- PRPO 9.9M
- ONFO 6.7M
- IPO Year
- PRPO N/A
- ONFO 2022
- Fundamental
- Price
- PRPO $7.22
- ONFO $1.35
- Analyst Decision
- PRPO
- ONFO
- Analyst Count
- PRPO 0
- ONFO 0
- Target Price
- PRPO N/A
- ONFO N/A
- AVG Volume (30 Days)
- PRPO 5.9K
- ONFO 11.8K
- Earning Date
- PRPO 03-28-2025
- ONFO 11-15-2024
- Dividend Yield
- PRPO N/A
- ONFO N/A
- EPS Growth
- PRPO N/A
- ONFO N/A
- EPS
- PRPO N/A
- ONFO N/A
- Revenue
- PRPO $17,411,000.00
- ONFO $6,590,171.00
- Revenue This Year
- PRPO $75.18
- ONFO $133.59
- Revenue Next Year
- PRPO N/A
- ONFO N/A
- P/E Ratio
- PRPO N/A
- ONFO N/A
- Revenue Growth
- PRPO 31.31
- ONFO 29.25
- 52 Week Low
- PRPO $4.31
- ONFO $0.39
- 52 Week High
- PRPO $7.55
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- PRPO 62.56
- ONFO 52.87
- Support Level
- PRPO $7.02
- ONFO $1.25
- Resistance Level
- PRPO $7.55
- ONFO $1.47
- Average True Range (ATR)
- PRPO 0.25
- ONFO 0.08
- MACD
- PRPO 0.05
- ONFO 0.02
- Stochastic Oscillator
- PRPO 73.78
- ONFO 53.57
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.